SCHEMBL4940530

SCHEMBL4940530

CC(=O)NS(=O)(=O)c1ccc2sc(C)nc2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 1.00
POLB P06746 1/20 0.57
SMN1; SMN2 Q16637 6/20 0.52
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
TP53 P04637 2/20 0.49
PKM P14618 4/20 0.49
LMNA P02545 6/20 0.48
HTT P42858 5/20 0.48
ALOX15 P16050 1/20 0.48
MAPK1 P28482 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
LDHA P00338 1/20 0.48
MEN1 O00255 1/20 0.47
CYP2C9 P11712 1/20 0.47
KMT2A Q03164 1/20 0.47
NOD2 Q9HC29 1/20 0.47
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL84337 0.79 POLB (0.66) ALDH1A1POLBSMN1; SMN2NPC1RAB9A
Hydrochloric Acid SCHEMBL27712068 0.78 POLB (0.64) ALDH1A1POLBSMN1; SMN2NPC1RAB9A
SCHEMBL6141396 0.77 POLB (0.68) ALDH1A1POLBSMN1; SMN2NPC1RAB9A
SCHEMBL10089770 0.77 ALDH1A1 (0.62) ALDH1A1POLBSMN1; SMN2NPC1RAB9A
SCHEMBL14612413 0.76 POLB (0.66) ALDH1A1POLBSMN1; SMN2NPC1RAB9A
SCHEMBL3524765 0.76 POLB (0.66) ALDH1A1POLBSMN1; SMN2NPC1RAB9A
SCHEMBL19750673 0.76 ALDH1A1 (0.60) ALDH1A1POLBSMN1; SMN2NPC1RAB9A
SCHEMBL15480586 0.75 ALDH1A1 (0.60) ALDH1A1POLBSMN1; SMN2NPC1RAB9A
SCHEMBL4940110 0.75 LMNA (0.60) ALDH1A1POLBSMN1; SMN2TP53PKM
SCHEMBL19749246 0.75 ALDH1A1 (0.60) ALDH1A1POLBSMN1; SMN2TP53PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080114041-A1 Benzothiazolesulfonamides ASTRAZENECA AB (SE) 2008-05-15 US claimed
US-20080114041-A1 Benzothiazolesulfonamides ASTRAZENECA AB (SE) 2008-05-15 US disclosed
US-20080114041-A1 Benzothiazolesulfonamides ASTRAZENECA AB (SE) 2008-05-15 US disclosed
US-20080114041-A1 Benzothiazolesulfonamides ASTRAZENECA AB (SE) 2008-05-15 US disclosed
EP-1833808-A1 NEW BENZOTHIAZOLESULFONAMIDES AstraZeneca AB (SE) 2007-09-19 EP disclosed
WO-2006068593-A1 NEW BENZOTHIAZOLESULFONAMIDES ASTRAZENECA AB (SE) 2006-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080114041-A1 Benzothiazolesulfonamides SULT1E1, TST, SULT1A1 ALDH1A1 382/4885POLB 3863/4885SMN1; SMN2 2496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.